 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/11/2019 |
$2.51 |
$2.57 |
$2.50 |
$2.54 |
123.50K | | 01/14/2019 |
$2.55 |
$2.58 |
$2.45 |
$2.46 |
157.80K | | 01/15/2019 |
$2.50 |
$2.54 |
$2.45 |
$2.51 |
191.00K | | 01/16/2019 |
$2.52 |
$2.63 |
$2.50 |
$2.63 |
548.00K | | 01/17/2019 |
$2.95 |
$2.95 |
$2.72 |
$2.88 |
2.01M |
|
|
| Adamis Pharmaceuticals is a specialty biopharmaceutical company. Co. develops and commercializes products in the therapeutic areas of respiratory disease and allergy. Co.'s products and product candidates include: Symjepi™ Injection 0.3mg for the treatment of acute allergic reactions and anaphylaxis; Symjepi™ Injection 0.15mg for the treatment of anaphylaxis for patients weighing 33-65 pounds; a naloxone injection product candidate for the treatment of opioid overdose; and, a beclomethasone metered dose inhaler and fluticasone dry powder inhaler for the treatment of asthma. Co. also provides prescription compounded medications, to patients, physician, and among others throughout the U.S. | |
|
Adamis Pharmaceuticals (ADMP) has the following price history information. Looking back at ADMP historical stock prices for the last five trading days, on January 11, 2019, ADMP opened at $2.51, traded as high as $2.57 and as low as $2.50, and closed at $2.54. Trading volume was a total of 123.50K shares. On January 14, 2019, ADMP opened at $2.55, traded as high as $2.58 and as low as $2.45, and closed at $2.46. Trading volume was a total of 157.80K shares. On January 15, 2019, ADMP opened at $2.50, traded as high as $2.54 and as low as $2.45, and closed at $2.51. Trading volume was a total of 191.00K shares. On January 16, 2019, ADMP opened at $2.52, traded as high as $2.63 and as low as $2.50, and closed at $2.63. Trading volume was a total of 548.00K shares. On January 17, 2019, ADMP opened at $2.95, traded as high as $2.95 and as low as $2.72, and closed at $2.88. Trading volume was a total of 2.01M shares.
ADMP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamis Pharmaceuticals shares, starting with a $10,000 purchase of ADMP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/20/2009 |
|
| End date: |
01/17/2019 |
|
| Start price/share: |
$0.51 |
|
| End price/share: |
$2.88 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
464.71% |
|
| Average Annual Total Return: |
18.91% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$56,490.80 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/11/2019 | $2.54 | | 01/14/2019 | $2.46 | | 01/15/2019 | $2.51 | | 01/16/2019 | $2.63 | | 01/17/2019 | $2.88 |
|
|
